EP-104IAR

N/A

Report date: 2025/09/02 17:34:38

Base Information

Drug NameEP-104IAR
Drug Alias NameFluticasone propionate controlled release (Eupraxia Pharmaceuticals)EP-104IAR
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsCytosolic phospholipase A2 agonists
TargetsGlucocorticoid receptorCytosolic phospholipase A2
Therapy Area/IndicationsPainEosinophilic EsophagitisOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaPoland +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEupraxia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEupraxia Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPainEosinophilic EsophagitisOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A